Aleafia Health Inc.
ALEAF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | -0.00 | 0.00 |
| FCF Yield | -359,838.07% | 124,769.54% | -389,563.63% | -398,524.70% |
| EV / EBITDA | -7.09 | -2.40 | 4.01 | 23.48 |
| Quality | ||||
| ROIC | -23.55% | -48.38% | 5.23% | -0.84% |
| Gross Margin | -21.07% | -122.85% | 147.79% | 47.53% |
| Cash Conversion Ratio | 0.15 | -0.06 | -0.24 | 0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.55% | 6.72% | 13.36% | 34.01% |
| Free Cash Flow Growth | -375.92% | 131.38% | -23.02% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -7.09 | -2.40 | 4.01 | 23.48 |
| Interest Coverage | -3.19 | -8.43 | 0.00 | -0.15 |
| Efficiency | ||||
| Inventory Turnover | 0.60 | 1.03 | -0.13 | 0.26 |
| Cash Conversion Cycle | 127.36 | 95.35 | -386.33 | 107.12 |